For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Ursodeoxycholic acid, also known as ursodiol (USAN) and the abbreviation UDCA, from the root-word for bear urso, as bear bile contains the substance, is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria. Ursodeoxycholic acid can be chemically synthesized and is marketed under multiple trade names, including Actigall, BILIVER, Coric, Deursil, Egyurso, Udiliv, UDOXYL, Urso, Urso Forte, Ursocol, Ursofalk, Ursosan and Ursoserinox.
The global ursodeoxycholic acid production, which measures output worldwide, was expected to reach xx tons in 2016 with an increase of xx% from its year-earlier level. The global ursodeoxycholic acid market size is estimated to grow from USD xx million in 2011 to USD xx million by 2016, at an estimated CAGR of xx% between 2011 and 2016. With regards to this, key players of ursodeoxycholic acid industry are expected to find potential opportunities in this market.
The global ursodeoxycholic acid market report profiles some of the key technological developments in the recent times. It also profiles some of the leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global ursodeoxycholic acid market are ICE, Daewoong Bio, Dipharma, Zhongshan Belling, Suzhou Tianlu, Mitsubishi, PharmaZell, Changde Yungang, Hengchanglong, Grindeks, etc.
The global ursodeoxycholic acid industry is relatively concentrated, with the market share of top 5 ursodeoxycholic acid producers at xx%.